These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23754532)

  • 1. Prediagnostic circulating markers of inflammation and risk of prostate cancer.
    Toriola AT; Laukkanen JA; Kurl S; Nyyssönen K; Ronkainen K; Kauhanen J
    Int J Cancer; 2013 Dec; 133(12):2961-7. PubMed ID: 23754532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory biomarker score and cancer: A population-based prospective cohort study.
    Morrison L; Laukkanen JA; Ronkainen K; Kurl S; Kauhanen J; Toriola AT
    BMC Cancer; 2016 Feb; 16():80. PubMed ID: 26860264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory serum markers and risk and severity of prostate cancer: The PROCA-life study.
    Stikbakke E; Richardsen E; Knutsen T; Wilsgaard T; Giovannucci EL; McTiernan A; Eggen AE; Haugnes HS; Thune I
    Int J Cancer; 2020 Jul; 147(1):84-92. PubMed ID: 31583707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The joint impact of prediagnostic inflammatory markers and cardiorespiratory fitness on the risk of cancer mortality.
    Pletnikoff PP; Laukkanen JA; Tuomainen TP; Kurl S
    Scand J Med Sci Sports; 2018 Feb; 28(2):613-620. PubMed ID: 28759130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, adipokines, and prostate cancer in a prospective population-based study.
    Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality.
    Stark JR; Li H; Kraft P; Kurth T; Giovannucci EL; Stampfer MJ; Ma J; Mucci LA
    Int J Cancer; 2009 Jun; 124(11):2683-9. PubMed ID: 19189403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
    Izano M; Wei EK; Tai C; Swede H; Gregorich S; Harris TB; Klepin H; Satterfield S; Murphy R; Newman AB; Rubin SM; Braithwaite D;
    Int J Cancer; 2016 Mar; 138(5):1118-28. PubMed ID: 26413860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population.
    Allin KH; Bojesen SE; Nordestgaard BG
    Int J Cancer; 2016 Oct; 139(7):1493-500. PubMed ID: 27194008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial.
    Beer TM; Lalani AS; Lee S; Mori M; Eilers KM; Curd JG; Henner WD; Ryan CW; Venner P; Ruether JD; Chi KN;
    Cancer; 2008 Jun; 112(11):2377-83. PubMed ID: 18428198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of C-reactive protein, fibrinogen, and cardiorespiratory fitness to risk of systemic hypertension in men.
    Jae SY; Kurl S; Laukkanen JA; Lee CD; Choi YH; Fernhall B; Franklin BA
    Am J Cardiol; 2015 Jun; 115(12):1714-9. PubMed ID: 25888302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cholesterol, C-reactive protein, and interleukin-6 on prostate cancer risk in a population of African ancestry.
    Tulloch-Reid MK; McFarlane-Anderson N; Bennett FI; Aiken WD; Jackson MD
    Cancer Causes Control; 2017 Nov; 28(11):1313-1321. PubMed ID: 28864928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum β-carotene in relation to risk of prostate cancer: the Kuopio Ischaemic Heart Disease Risk Factor study.
    Karppi J; Kurl S; Laukkanen JA; Kauhanen J
    Nutr Cancer; 2012 Apr; 64(3):361-7. PubMed ID: 22420939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein concentrations and subsequent ovarian cancer risk.
    McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
    Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.
    Seddon JM; George S; Rosner B; Rifai N
    Arch Ophthalmol; 2005 Jun; 123(6):774-82. PubMed ID: 15955978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation.
    Van Hemelrijck M; Jungner I; Walldius G; Garmo H; Binda E; Hayday A; Lambe M; Holmberg L; Hammar N
    Int J Cancer; 2011 Sep; 129(6):1485-92. PubMed ID: 21792885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study.
    Arthur R; Williams R; Garmo H; Holmberg L; Stattin P; Malmström H; Lambe M; Hammar N; Walldius G; Robinsson D; Jungner I; Van Hemelrijck M
    Int J Cancer; 2018 Jun; 142(11):2254-2262. PubMed ID: 29322512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of inflammation and weight change in middle-aged adults: results from the prospective MONICA/KORA S3/F3 study.
    Holz T; Thorand B; Döring A; Schneider A; Meisinger C; Koenig W
    Obesity (Silver Spring); 2010 Dec; 18(12):2347-53. PubMed ID: 20360759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediagnostic plasma vitamin C levels and the subsequent risk of prostate cancer.
    Berndt SI; Carter HB; Landis PK; Hallfrisch J; Rohrmann S; Metter EJ; Platz EA
    Nutrition; 2005 Jun; 21(6):686-90. PubMed ID: 15925292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity C-reactive protein is an independent risk factor for non-vertebral fractures in women and men: The Tromsø Study.
    Dahl K; Ahmed LA; Joakimsen RM; Jørgensen L; Eggen AE; Eriksen EF; Bjørnerem Å
    Bone; 2015 Mar; 72():65-70. PubMed ID: 25460573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.